PhD in Drug Discovery, Medicinal Chemistry, Chemical Biology, or Structural Biophysics and In Silico Modelling at GSK and University of Strathclyde University of Strathclyde in United Kingdom

PhD opportunity at the University of St Andrews in the School of Biology / School of Chemistry, working on design, synthesis, and mechanism of action of inhibitors of the human enzyme DNPH1 (2′-deoxynucleoside 5′-phosphate N-hydrolase 1). This project sits at the interface of Biochemistry , Structural Biology , Medicinal Chemistry , Organic Synthesis , and Chemical Biology . DNPH1 is a nucleotide-sanitizing enzyme, and the project aims to design potent and selective inhibitors and elucidate how ...

Fully funded postdoctoral position at the University of Connecticut in the Bahal Lab , School of Pharmacy and Pharmaceutical Sciences, focused on organic chemistry , medicinal chemistry , glycochemistry , chemical biology , and nucleic acid therapeutics . The role is aimed at candidates with a strong background in organic synthesis and a publication record. The post explicitly states that a PhD in Organic Chemistry, Medicinal Chemistry, Chemical Biology, or a related field is required. This is a...

University of Bath is recruiting a Postdoctoral Research Associate in an interdisciplinary project focused on mammalian cell biology , molecular biology , chemical biology , and peptide screening . The work will develop innovative intracellular peptide screening technologies to investigate and modulate transcription factor function in living mammalian cells. The post is hosted in Professor Jody Mason's research group at the University of Bath and is funded through a new BBSRC Pioneer Award . The...

Two fully funded PhD studentships are open in the group of Professor Glenn Burley at the University of Strathclyde, in partnership with GSK. These projects sit at the interface of chemistry and biology and focus on nucleic acid-based therapeutics. Project 1: Next-generation RNA-PROTACs — a direct-to-biology discovery platform for the targeted degradation of RNA-binding proteins. The project will develop RNA-PROTACs assembled and assayed in cells, combining therapeutic oligonucleotide synthesis, ...

PhD studentships are available through the University of Strathclyde’s collaborative research partnership with GSK. The opportunity is for PhD research in Medicinal Chemistry , Chemical Biology , and Structural Biophysics , with studentships starting in October 2027 . Funding covers home/UK fees only . The post does not mention a stipend, international fee coverage, or other financial details. The announcement is shared by Laura Paterson, Strathclyde Manager of the Collaborative GSK Research Pro...